血液造血干细胞中的线粒体质量控制:机制,含义和治疗机会
Yun Liao1,2, Stacia Octaviani1, Zhen Tian1
1Coriell Institute for Medical Research, Camden, NJ, USA.
Stem cell research & therapy
|April 15, 2025
概括
线粒体质量控制 (MQC) 通过线粒体和生物发生维持血造干细胞 (HSC) 功能. 了解MQC机制是治疗血液疾病和改善治疗的关键.
科学领域:
- 细胞生物学 细胞生物学
- 血液学 血液学 血液学
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体质量控制 (MQC) 对于造血干细胞 (HSC) 的自我更新和稳定性至关重要.
- 关键的MQC过程包括线粒细胞分裂,生物发生,裂变,融合和线粒体转移.
研究的目的:
- 审查MQC在HSC中的分子机制.
- 在生理和病理条件下探索MQC功能.
- 讨论MQC的潜在治疗应用.
主要方法:
- 在HSC中对MQC机制的文献综述.
- 分析MQC在HSC功能和平衡中所扮演的角色.
- 检查MQC在造血性疾病和治疗耐药性的检查.
主要成果:
- 包括线粒细胞和生物发生在内的MQC对HSC功能和预防衰老至关重要.
- 线粒体转移支持HSC损伤修复和代谢需求.
- 功能障碍的MQC可能会导致造血性疾病和治疗失败.
结论:
- 需要进一步的研究,以充分阐明MQC分子机制和通路相互作用.
- 在疾病进展中MQC功能障碍的作用需要更深入的理解.
- 准MQC为血液学中新的治疗策略提供了潜力.
关键词:
造血干细胞是造血干细胞的组成部分.线粒体生物发生是线粒体生物发生.线粒体动力学的动态线粒体代谢的代谢过程线粒体质量控制的质量控制线粒体转移是指线粒体转移.线粒细胞衰变 - - 线粒细胞衰变 (mitophagy) 是一种更多相关视频
07:57Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
Published on: December 26, 2019
10:17Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
Published on: September 24, 2021
相关概念视频
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
